<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36834970</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways-Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3560</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24043560</ELocationID><Abstract><AbstractText>Fatigue is a widespread and complex symptom with motor and cognitive components; it is diagnosed predominantly by questionnaire. We recently published a correlation between anti-N-methyl-D-aspartate receptor (NMDAR) antibodies and fatigue in patients with SLE (systemic lupus erythematosus). In the present study, we examined whether this association also applies to patients with other rheumatic diseases. Serum samples of 88 patients with different rheumatic diseases were analyzed for the presence of anti-NR2 antibodies and Neurofilament light chain (NfL) protein. The severity of fatigue was determined according to the FSMC questionnaire (Fatigue Scale for Motor and Cognitive Functions) and correlated with the circulating antibody titer and NfL level accordingly. Positive titers of anti-NR2 antibodies were detected in patients with both autoimmune and non-autoimmune rheumatic diseases. These patients suffer predominantly from severe fatigue. The circulating NfL level did not correlate with the anti-NR2 titer and the fatigue severity in all patient groups. The association of severe fatigue with circulating anti-NR2 antibodies in patients with rheumatic diseases, independently from the main disease, suggests an individual role of these autoantibodies in fatigue pathophysiology. Thus, the detection of these autoantibodies might be a helpful diagnostic tool in rheumatic patients with fatigue.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marinoska</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Rheumatic Disease Rhineland-Palatinate, 55543 Bad Kreuznach, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf6;ckel</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2167-8369</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology and Clinical Immunology, University Medical Center of the Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triantafyllias</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Rheumatic Disease Rhineland-Palatinate, 55543 Bad Kreuznach, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology and Clinical Immunology, University Medical Center of the Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boegel</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Rheumatology and Clinical Immunology, University Medical Center of the Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreher</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Rheumatology and Clinical Immunology, University Medical Center of the Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Center for Autoimmune Disease, University Medical Center of the Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luessi</LastName><ForeName>Felix</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4334-4199</Identifier><AffiliationInfo><Affiliation>University Center for Autoimmune Disease, University Medical Center of the Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, University Medical Center of the Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwarting</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Rheumatic Disease Rhineland-Palatinate, 55543 Bad Kreuznach, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology and Clinical Immunology, University Medical Center of the Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Center for Autoimmune Disease, University Medical Center of the Johannes Gutenberg University of Mainz, 55131 Mainz, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C031959">aspartic acid receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016194">Receptors, N-Methyl-D-Aspartate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="Y">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016194" MajorTopicYN="Y">Receptors, N-Methyl-D-Aspartate</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-NMDAR2 antibodies</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">neurofilament light chain</Keyword><Keyword MajorTopicYN="N">rheumatic diseases</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36834970</ArticleId><ArticleId IdType="pmc">PMC9964077</ArticleId><ArticleId IdType="doi">10.3390/ijms24043560</ArticleId><ArticleId IdType="pii">ijms24043560</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Overman C.L., Kool M.B., Da Silva J.A., Geenen R. The prevalence of severe fatigue in rheumatic diseases: An international study. Clin. Rheumatol. 2016;35:409&#x2013;415. doi: 10.1007/s10067-015-3035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-015-3035-6</ArticleId><ArticleId IdType="pmc">PMC4752960</ArticleId><ArticleId IdType="pubmed">26272057</ArticleId></ArticleIdList></Reference><Reference><Citation>Flessa C.M., Zampeli E., Evangelopoulos M.E., Natsis V., Bodewes I.L.A., Huijser E., Versnel M.A., Moutsopoulos H.M., Mavragani C.P. Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients with Primary Sjogren&#xa0;s Syndrome. Front. Immunol. 2022;13:836824. doi: 10.3389/fimmu.2022.836824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.836824</ArticleId><ArticleId IdType="pmc">PMC8964489</ArticleId><ArticleId IdType="pubmed">35371038</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe6;land E., Miyamoto S.T., Hammenfors D., Valim V., Jonsson M.V. Understanding Fatigue in Sj&#xf6;gren&#xa0;s Syndrome: Outcome Measures, Biomarkers and Possible Interventions. Front. Immunol. 2021;12:703079. doi: 10.3389/fimmu.2021.703079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.703079</ArticleId><ArticleId IdType="pmc">PMC8267792</ArticleId><ArticleId IdType="pubmed">34249008</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard Tripp N., Tarn J., Natasari A., Gillespie C., Mitchell S., Hackett K.L., Bowman S.J., Price E., Pease C.T., Emery P., et al. Fatigue in primary Sj&#xf6;gren&#xa0;s syndrome is associated with lower levels of proinflammatory cytokines. RMD Open. 2016;2:e000282. doi: 10.1136/rmdopen-2016-000282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2016-000282</ArticleId><ArticleId IdType="pmc">PMC4964201</ArticleId><ArticleId IdType="pubmed">27493792</ArticleId></ArticleIdList></Reference><Reference><Citation>Karageorgas T., Fragioudaki S., Nezos A., Karaiskos D., Moutsopoulos H.M., Mavragani C.P. Fatigue in Primary Sj&#xf6;gren&#xa0;s Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations. Arthritis Care Res. 2016;68:123&#x2013;131. doi: 10.1002/acr.22720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22720</ArticleId><ArticleId IdType="pubmed">26315379</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo C., Martinez-Suarez E., Kechida M., Isetta M., Serra-Mestres J. Cognitive Function in Primary Sj&#xf6;gren&#xa0;s Syndrome: A Systematic Review. Brain Sci. 2019;9:85. doi: 10.3390/brainsci9040085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci9040085</ArticleId><ArticleId IdType="pmc">PMC6523842</ArticleId><ArticleId IdType="pubmed">30991679</ArticleId></ArticleIdList></Reference><Reference><Citation>Korte S.M., Straub R.H. Fatigue in inflammatory rheumatic disorders: Pathophysiological mechanisms. Rheumatology. 2019;58:v35&#x2013;v50. doi: 10.1093/rheumatology/kez413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kez413</ArticleId><ArticleId IdType="pmc">PMC6827268</ArticleId><ArticleId IdType="pubmed">31682277</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Che L., Cai X., Zhu P., Ran J. Bioinformatic Analysis Identifies Biomarkers and Treatment Targets in Primary Sj&#xf6;gren&#xa0;s Syndrome Patients with Fatigue. BioMed Res. Int. 2022;2022:7697558. doi: 10.1155/2022/7697558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7697558</ArticleId><ArticleId IdType="pmc">PMC8783724</ArticleId><ArticleId IdType="pubmed">35075430</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison M.J., Ravdin L.D., Lockshin M.D. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2515&#x2013;2522. doi: 10.1002/art.22030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22030</ArticleId><ArticleId IdType="pubmed">16868972</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowling T.K., Kral M., Wolf B., Gilkeson G., Ruth N.M. Formal neurocognitive function and anti-N-methyl-D-aspartate receptor antibodies in paediatric lupus. Lupus Sci. Med. 2021;8:e000462. doi: 10.1136/lupus-2020-000462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2020-000462</ArticleId><ArticleId IdType="pmc">PMC7993203</ArticleId><ArticleId IdType="pubmed">33758010</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarting A., M&#xf6;ckel T., L&#xfc;tgendorf F., Triantafyllias K., Grella S., Boedecker S., Weinmann A., Meineck M., Sommer C., Schermuly I., et al. Fatigue in SLE: Diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies. Ann. Rheum. Dis. 2019;78:1226&#x2013;1234. doi: 10.1136/annrheumdis-2019-215098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215098</ArticleId><ArticleId IdType="pubmed">31186256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wollmuth L.P., Chan K., Groc L. The diverse and complex modes of action of anti-NMDA receptor autoantibodies. Neuropharmacology. 2021;194:108624. doi: 10.1016/j.neuropharm.2021.108624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2021.108624</ArticleId><ArticleId IdType="pmc">PMC8693782</ArticleId><ArticleId IdType="pubmed">34081993</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner I.K., Raselli C., St&#xf6;cklin M., Opwis K., Kappos L., Calabrese P. The Fatigue Scale for Motor and Cognitive Functions (FSMC): Validation of a new instrument to assess multiple sclerosis-related fatigue. Mult. Scler. J. 2009;15:1509&#x2013;1517. doi: 10.1177/1352458509348519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458509348519</ArticleId><ArticleId IdType="pubmed">19995840</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B. Diamond, B A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 2001;7:1189&#x2013;1193. doi: 10.1038/nm1101-1189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1101-1189</ArticleId><ArticleId IdType="pubmed">11689882</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapteva L., Nowak M., Yarboro C.H., Takada K., Roebuck-Spencer T., Weickert T., Bleiberg J., Rosenstein D., Pao M., Patronas N., et al. Anti&#x2013;N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2505&#x2013;2514. doi: 10.1002/art.22031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22031</ArticleId><ArticleId IdType="pubmed">16868971</ArticleId></ArticleIdList></Reference><Reference><Citation>Omdal R., Brokstad K., Waterloo K., Koldingsnes W., Jonsson R., Mellgren S.I. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur. J. Neurol. 2005;12:392&#x2013;398. doi: 10.1111/j.1468-1331.2004.00976.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2004.00976.x</ArticleId><ArticleId IdType="pubmed">15804272</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauvsnes M.B., Beyer M.K., Kval&#xf8;y J.T., Greve O.J., Appenzeller S., Kvivik I., Harboe E., Tjensvoll A.B., G&#xf8;ransson L.G., Omdal R. Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sj&#xf6;gren&#xa0;s syndrome. Arthritis Rheumatol. 2014;66:3387&#x2013;3394. doi: 10.1002/art.38852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38852</ArticleId><ArticleId IdType="pubmed">25156222</ArticleId></ArticleIdList></Reference><Reference><Citation>Schramm M.A., Venhoff N. NMDAR autoantibodies as biomarker for fatigue in SLE. Z. F&#xfc;r Rheumatol. 2020;79:83&#x2013;84. doi: 10.1007/s00393-019-00739-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00393-019-00739-5</ArticleId><ArticleId IdType="pubmed">31822994</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastaldi V.D., Wilke J.B., Weidinger C.A., Walter C., Barnkothe N., Teegen B., Luessi F., St&#xf6;cker W., L&#xfc;hder F., Begemann M., et al. Factors predisposing to humoral autoimmunity against brain-antigens in health and disease Analysis of 49 autoantibodies in over 7000 subjects. Brain Behav. Immun. 2022;108:135&#x2013;147. doi: 10.1016/j.bbi.2022.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.10.016</ArticleId><ArticleId IdType="pubmed">36323361</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati G., Iffland P.H., Janigro D., Zhang B., Luggen M.E. Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction. Clin. Rheumatol. 2016;35:2989&#x2013;2997. doi: 10.1007/s10067-016-3339-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-016-3339-1</ArticleId><ArticleId IdType="pubmed">27357716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., Volpe B.T. Cognition and immunity, antibody impairs memory. Immunity. 2004;21:179&#x2013;188. doi: 10.1016/j.immuni.2004.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2004.07.011</ArticleId><ArticleId IdType="pubmed">15308099</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanella I., Blasco H., Filosto M., Biasiotto G. Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases. Front. Neurosci. 2022;16:915115. doi: 10.3389/fnins.2022.915115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.915115</ArticleId><ArticleId IdType="pmc">PMC9117738</ArticleId><ArticleId IdType="pubmed">35600631</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel S., Boedecker S., Marczynski P., Bittner S., Steffen F., Weinmann A., Schwarting A., Zipp F., Weinmann-Menke J., Luessi F. Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus. Ther. Adv. Neurol. Disord. 2021;14:17562864211051497. doi: 10.1177/17562864211051497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562864211051497</ArticleId><ArticleId IdType="pmc">PMC8543555</ArticleId><ArticleId IdType="pubmed">34707690</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjensvoll A.B., Lauvsnes M.B., Zetterberg H., Kval&#xf8;y J.T., Kvivik I., Maroni S.S., Greve O.J., Beyer M.K., Hirohata S., Putterman C. Neurofilament light is a biomarker of brain involvement in lupus and primary Sj&#xf6;gren&#xa0;s syndrome. J. Neurol. 2021;268:1385&#x2013;1394. doi: 10.1007/s00415-020-10290-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10290-y</ArticleId><ArticleId IdType="pmc">PMC7990817</ArticleId><ArticleId IdType="pubmed">33128084</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauvsnes M.B., Zetterberg H., Blennow K., Kval&#xf8;y J.T., Tjensvoll A.B., Maroni S., Beyer M.K., Greve O.J., Kvivik I., Alves G. Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus. J. Neurol. 2022;269:3064&#x2013;3074. doi: 10.1007/s00415-021-10893-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10893-z</ArticleId><ArticleId IdType="pubmed">34800169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki P., Helve T., Dahl D., Virtanen I. Neurofilament antibodies in systemic lupus erythematosus. J. Rheumatol. 1986;13:69&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">3517324</ArticleId></ArticleIdList></Reference><Reference><Citation>Mader S., Brimberg L., Diamond B. The Role of Brain-Reactive Autoantibodies in Brain Pathology and Cognitive Impairment. Front. Immunol. 2017;8:1101. doi: 10.3389/fimmu.2017.01101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01101</ArticleId><ArticleId IdType="pmc">PMC5601985</ArticleId><ArticleId IdType="pubmed">28955334</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang E.H., Volpe B.T., Mackay M., Aranow C., Watson P., Kowal C., Storbeck J., Mattis P., Berlin R., Chen H., et al. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor. EBioMedicine. 2015;2:755&#x2013;764. doi: 10.1016/j.ebiom.2015.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2015.05.027</ArticleId><ArticleId IdType="pmc">PMC4534689</ArticleId><ArticleId IdType="pubmed">26286205</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkert P., Meier S., Schaedelin S. NfL Reference Database in the Swiss Multiple Sclerosis Cohort Study Group. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: A retrospective modelling and validation study. Lancet Neurol. 2022;21:246&#x2013;257. doi: 10.1016/S1474-4422(22)00009-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00009-6</ArticleId><ArticleId IdType="pubmed">35182510</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>